EY is unable to publish many of its current qui tam/False Claims Act cases because they are required to remain under court-imposed seal. Below are details from numerous past cases successfully litigated by EY attorneys:

Pfizer Inc., $2.3 Billion Dollar Qui Tam Settlement (U.S. ex. rel. Collins v. Pfizer, Inc.; U.S. ex. rel. Kopchinski v. Pfizer, Inc.; U.S. ex. rel. Spencer v. Pfizer, Inc.; U.S. ex rel. DeMott v. Pfizer; U.S. ex. rel. Farber v. Pfizer; U.S. ex. rel. Rainero v. Pfizer; U.S. ex. rel. Westlock v. Pfizer, Inc.; U.S. ex. rel. Liter v. Pfizer; and U.S. ex. rel. Kruszewski v. Pfizer, Inc.).

On September 2, 2009, Pfizer, Inc. announced it agreed to plead guilty to criminal conduct and to pay more than $2 billion in criminal and civil fines, penalties and damages to settle allegations made in multiple whistleblower lawsuits that the pharmaceutical giant defrauded Medicare, Medicaid and other government-funded health care programs in connection with its market practices for four of its drugs. The settlement is the largest qui tam settlement in U.S. history.  EY Partner Eric L. Young served as counsel of record for several whistleblowers in what is the largest qui tam settlement in U.S. history.

United States ex. rel. Lucia Paccione v. Cephalon Inc. E.D.Pa., Case No. 036268.

EY Partner Eric L. Young served as co-counsel of record on behalf of Lucia Paccione, a former Cephalon sales representative who filed a qui tam complaint reporting America's largest biotechnology Medicaid fraud case. The case involved unlawful off-label marketing by Cephalon of drugs including Gabitril, Actiq, and Provigil.  On September 29, 2008, it was announced that Ms. Paccione's qui tam complaint led to the federal and numerous state governments' recovery of $425 Million in a Civil Settlement.

United States ex rel Kelly v. Biotrax Inc., Fresensius Medical Care AG, Eastern District of Pennsylvania CA No. 96-1441.